Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
41.49
+1.95 (4.93%)
Dec 20, 2024, 4:00 PM EST - Market closed
Protagonist Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 170.85 | -78.96 | -127.39 | -125.55 | -66.15 | -77.19 | Upgrade
|
| Depreciation & Amortization | 3.19 | 3.31 | 3.37 | 2.78 | 2.72 | 2.52 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | -7.46 | -4.57 | -0.55 | 1.83 | 0.04 | -0.59 | Upgrade
|
| Stock-Based Compensation | 35.06 | 29.29 | 24.2 | 16.4 | 7.9 | 8.35 | Upgrade
|
| Other Operating Activities | - | 0.19 | - | - | 2.02 | -0.78 | Upgrade
|
| Change in Accounts Receivable | - | -9.99 | 1.56 | 0.86 | 4.33 | -2.17 | Upgrade
|
| Change in Accounts Payable | 1.68 | -2.87 | 2.05 | -1.39 | 0.31 | -3 | Upgrade
|
| Change in Unearned Revenue | 36.21 | - | -1.6 | -12.88 | -27.05 | 33.31 | Upgrade
|
| Change in Other Net Operating Assets | -10.28 | -6.65 | -9.77 | 10.09 | 3.4 | -2 | Upgrade
|
| Operating Cash Flow | 230.29 | -70.24 | -108.14 | -107.87 | -72.48 | -41.53 | Upgrade
|
| Capital Expenditures | -1.06 | -0.61 | -0.8 | -1.1 | -0.47 | -0.97 | Upgrade
|
| Investment in Securities | -350.98 | -38.65 | 92.26 | -14.76 | -90.49 | -52.74 | Upgrade
|
| Investing Cash Flow | -352.05 | -39.26 | 91.47 | -15.86 | -90.97 | -53.71 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 9.77 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -10.52 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | -10.52 | 9.77 | Upgrade
|
| Issuance of Common Stock | 22.95 | 171.25 | 19 | 130.11 | 258.16 | 36.27 | Upgrade
|
| Repurchase of Common Stock | -0.6 | -0.77 | -0.19 | -0.19 | - | - | Upgrade
|
| Other Financing Activities | - | - | 0.03 | - | -0.01 | - | Upgrade
|
| Financing Cash Flow | 22.35 | 170.48 | 18.84 | 129.92 | 247.63 | 46.04 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | -0.09 | -0.13 | 0.18 | -0.03 | Upgrade
|
| Net Cash Flow | -99.41 | 60.98 | 2.08 | 6.07 | 84.35 | -49.23 | Upgrade
|
| Free Cash Flow | 229.23 | -70.85 | -108.93 | -108.97 | -72.96 | -42.49 | Upgrade
|
| Free Cash Flow Margin | 70.79% | -118.08% | -409.81% | -398.31% | -254.84% | -18395.67% | Upgrade
|
| Free Cash Flow Per Share | 3.61 | -1.25 | -2.22 | -2.35 | -2.12 | -1.64 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.44 | 0.07 | Upgrade
|
| Levered Free Cash Flow | 144.94 | -43.31 | -60.37 | -61.59 | -23.42 | -36.17 | Upgrade
|
| Unlevered Free Cash Flow | 144.94 | -43.31 | -60.37 | -61.59 | -23.04 | -36.07 | Upgrade
|
| Change in Net Working Capital | -14.55 | 16.77 | 5.04 | 1.01 | -7.13 | -4.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.